NimbleGen Systems — a Madison biotechnology company and UW spinoff that created a new way to make gene chips — plans to raise up to $75 million in an initial public stock offering.
Office of Strategic Communication
NimbleGen Systems — a Madison biotechnology company and UW spinoff that created a new way to make gene chips — plans to raise up to $75 million in an initial public stock offering.